Arun Kejriwal, a primary capital market expert and owner of AK47, also feels the stock price may adjust near its issue price before the listing
JM Financial says while the capital infusion and AT1 bonds write-off has helped Yes Bank stay afloat, its fundamentals remain weak.
"Deposit run-down will continue especially post moratorium and with smaller balance size and lower opex levers, we expect operating profitability to be dramatically impacted," says Nomura.
The restructuring of Yes Bank has to be seen in the light of failures of the NBFCs, IL&FS and DHFL and the crisis in banks like PMC Bank and PNB.
The first and foremost effect of the Yes Bank crisis was on Life Insurance Corporation of India.
"The new capital will likely come in at a steep discount to current share price, as forced 'bailout' investors will likely want a large cut for equity holders," the brokerage said.
Ashwani Gujral of ashwanigujral.com recommends buying Chambal Fertilizers with a stop loss of Rs 175, target of Rs 190 and Muthoot Finance with a stop loss of Rs 768, target of Rs 790.
The BSE small-cap index added 1.13 percent, BSE large-cap index was up 0.27 percent and the BSE mid-cap index rose 0.29 percent while in the past week.
Lower interest rates and good monsoon are expected to help the economy. Also, positive developments in the global arena for the US-China trade deal and the Brexit resolution will provide additional support
VK Vijaykumar of Geojit Financial Service feels the proposed AIF is better than the earlier one since this also includes projects referred to NCLT.
Emkay, which has a sell rating on the stock, believes unabated stress flow will keep the profit & loss bleeding and call for prolonged dilution risk for investors
The benchmark indices continued their rally for the sixth consecutive session on November 1, with Sensex touched a fresh all-time high of 40,392.22.
The S&P BSE Mid-cap index gained 4.64 percent, S&P BSE Large-cap index rose 3.49 percent and the Small-cap Index was up 2.78 percent last week.
The S&P BSE Midcap index surged 3.3 percent and S&P BSE Largecap Index added 1.89 percent, while Smallcap Index was up 1.47 percent last week.
Prakash Gaba of prakashgaba.com recommends buying Sun Pharma with target at Rs 455 and stop loss at Rs 435.
The index is likely to face resistance around 11,080, followed by 11,120 while supports are placed at 10,990, and 10,950 levels
But not all earnings are bad in June quarter, there are few stocks which brokerages upgraded their rating either on hope of further growth or worth seems to have priced in.
Bank Nifty options data for upcoming weekly expiry depicts 31,000 as strong support as aggressive Put writing is seen at 31,000 and on upside the highest Call OI is at 32,000, which can act as strong resistance
On May 16, S&P BSE Oil & Gas rose 1.5 percent, followed by the S&P BSE realty that gained 1.3 percent, and the S&P BSE Power that was up 1.3 percent
Sun Pharma has support around 370-390 but it seems unlikely that the stock will hold on to that level.
Among sectors, FMCG, IT, pharma lost more than 2 percent, while metal and energy index seen some buying.
On April 26 the company reported its biggest quarterly loss in 14 years at Rs 1,507 crore for the quarter ended March 31.
Sudarshan Sukhani of s2analytics.com recommends buying Kotak Mahindra Bank with stop loss at Rs 1355 and target of Rs 1395 and Infosys with stop loss at Rs 732 and target of Rs 745.
Sudarshan Sukhani of s2analytics.com recommends buying Mahindra & Mahindra with stop loss at Rs 660 and target of Rs 675, Divis Labs with stop loss at Rs 1698 and target of Rs 1730 and United Spirits with stop loss at Rs 536 and target of Rs 565.
Sudarshan Sukhani of s2analytics.com recommends buying Tata Consultancy Services with stop loss at Rs 2055 and target of Rs 2100, Infosys with stop loss at Rs 743 and target of Rs 761 and V-Guard Industries with stop loss at Rs 218 and target of Rs 226.